Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • EMR vs GSK✓SelectedUSD · GSKEMR vs GSK performance historyLatest closeAs of-2.72%11/19
Stock and ETF performance explorer

EMR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+86.1%
GSK return
+39.6%
Excess return
+46.5%
Maximum drawdown
-29.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.7%-1.6%-1.2%-2.4%
7D-5.2%-4.7%-0.5%-4.4%
30D-1.4%-4.7%+3.3%-0.6%
3M+0.4%-8.8%+9.1%+2.1%
6M+21.5%-4.6%+26.1%+22.1%
YTD+20.5%+1.0%+19.5%+20.0%
1Y+24.8%+6.9%+17.9%+23.0%
3Y+85.7%+52.5%+33.1%+66.9%
5Y+86.1%+40.3%+45.8%+58.1%
All+86.1%+39.6%+46.5%+58.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling